Q2 2019 Catabasis Pharmaceuticals Inc Earnings Call Transcript
Good day, ladies and gentlemen, and welcome to the Q2 2019 Catabasis Pharmaceuticals, Inc. Earnings Conference Call. (Operator Instructions)
I would now like to turn the call over to Andrea Matthews, Vice President, Corporate Affairs. Ma'am, you may begin.
Thank you, Sydney. Welcome to today's Catabasis Pharmaceuticals conference call where we will provide a corporate update and review our second quarter 2019 financial results. With me today are Jill Milne, Chief Executive Officer; Joanne Donovan, Chief Medical Officer; Andrew Nichols, Chief Scientific Officer; and Noah Clauser, Vice President of Finance.
We issued a press release this morning summarizing our corporate update and our Q2 2019 financial results, which we will reference on today's call and is available on our website. We are also using slides during today's call that are available within the Events and Presentations section in the investors part of our website.
I would like to note that
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |